DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Total Current Liabilities of $54.3 million for Q2 2026, up 9.86% year-on-year from $49.4 million in Q2 2025, and up 4.83% on a QoQ basis from $51.8 million in Q1 2026.

DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Total Current Liabilities for 12 consecutive years, with $54.3 million the latest figure, recorded in Q2 2026.

  • Quarterly Total Current Liabilities rose 9.86% year-over-year to $54.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $54.3 million (up 9.86% YoY) and the FY2025 annual result came in at $58.0 million, up 86.28% from the prior year.
  • Total Current Liabilities advanced to $54.3 million in Q2 2026 per DBVT's latest filing, from $51.8 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for DBVT reached as high as $58.0 million in Q4 2025 and fell as low as $26.0 million in Q1 2022.
  • A 5-year average of $37.1 million and a median of $32.1 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 32.96% — and 2025, when it jumped 86.28%.
  • Year by year, Total Current Liabilities stood at $29.5 million in 2022, then rose by 26.48% to $37.3 million in 2023, then retreated by 16.61% to $31.1 million in 2024, then surged by 86.28% to $58.0 million in 2025, then fell by 6.38% to $54.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $54.3 million, $51.8 million, and $58.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 54.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 54.30 Mn
Mar 31, 2026 51.80 Mn
Dec 31, 2025 58.00 Mn
Sep 30, 2025 49.49 Mn
Jun 30, 2025 49.43 Mn
Mar 31, 2025 40.38 Mn
Dec 31, 2024 31.14 Mn
Sep 30, 2024 30.91 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 26.48 Mn
Dec 31, 2023 37.34 Mn
Sep 30, 2023 31.44 Mn
Jun 30, 2023 33.37 Mn
Mar 31, 2023 32.78 Mn
Dec 31, 2022 29.52 Mn
Sep 30, 2022 28.39 Mn
Jun 30, 2022 30.43 Mn
Mar 31, 2022 26.03 Mn
Dec 31, 2021 31.40 Mn
Sep 30, 2021 33.81 Mn